Mi­cro­cap gene ther­a­py play­er says three chil­dren suf­fered se­ri­ous side ef­fects in PhI/II study

A small biotech look­ing to de­vel­op a gene ther­a­py for a rare con­di­tion that can cause col­or or le­gal blind­ness ran in­to some sig­nif­i­cant safe­ty …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA